BusinessElite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National ConferenceBy Nasdaq OMXAug 30, 2017, 12:01 PM UTC
BusinessElite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study for Reformulated SequestOx™By Nasdaq OMXMar 13, 2017, 12:00 PM UTC
BusinessElite Announces U.S. FDA Priority Review Designation for SequestOx™ NDABy Nasdaq OMXMar 17, 2016, 11:00 AM UTC
BusinessElite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016By Nasdaq OMXFeb 9, 2016, 9:31 PM UTC
